CoChat

The effect of Haemophilus influenzaetype B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review

Open access
Davis, Stephanie, Feikin, Daniel, Johnson, Hope L · 2013 · BMC Public Health
Cited by 71

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Two of the most prevalent causes of severe bacterial meningitis in children, Haemophilus influenzae type B (Hib) and Streptococcus pneumoniae, are preventable by existing vaccines increasingly available in developing countries. Our objective was to estimate the dose-specific effect of Hib and pneumococcal conjugate vaccines (PCV) on childhood meningitis mortality in low-income countries for use in the Lives Saved Tool (LiST). METHODS: We systematically searched and reviewed published vaccine efficacy trials and observational studies reporting the effect of Hib or PCV vaccines on organism-specific meningitis, bacterial meningitis and all-cause meningitis incidence and mortality among children less than five years old in low- and middle-income countries. Data collection and quality assessments were performed using standardized guidelines. For outcomes available across multiple studies (≥ 2) and approximating meningitis mortality, we pooled estimates reporting dose-specific effects using random effects meta-analytic methods, then combined these with meningitis etiology data to determine the preventable fraction of childhood meningitis mortality for inclusion in LiST. RESULTS: We identified 18 studies of Hib conjugate vaccines reporting relevant meningitis morbidity and mortality outcomes (2 randomized controlled trials [RCTs], 16 observational studies) but few provided dose-specific effects. A meta-analysis of four case-control studies examined the dose-specific effect of Hib conjugate vaccines on Hib meningitis morbidity (1 dose: RR=0.64, 95% CI 0.38-1.06; 2 doses: RR=0.09, 95% CI 0.03-0.27; 3 doses: RR=0.06, 95% CI 0.02-0.22), consistent with results from single RCTs. Pooled estimates of two RCTs provided evidence for the effect of three doses of PCV on vaccine-serotype meningitis morbidity (RR=0.16, 95% CI 0.02-1.20). We considered these outcomes of severe disease as proxy estimates for meningitis mortality and combined the estimates of protective effects with meningitis etiology data to provide an estimate of the preventable fraction of childhood meningitis mortality with three doses of Hib (38-43%) and pneumococcal conjugate vaccines (28-35%) for use in LiST. CONCLUSIONS: Few RCTs or vaccine effectiveness studies evaluated the dose-specific impact of Hib and PCV vaccines on childhood meningitis mortality, necessitating use of proxy measures to estimate population impact in LiST. Our analysis indicates that approximately three-quarters of meningitis deaths are preventable with existing Hib and PCV vaccines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2458-13-s3-s21

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 62

  1. Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RAN, Nohynek H, Riley ID, Makela H: Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age (Review). The Cochrane Library. 2009, 4:
  2. Swingler GH, Michaels D, Hussey GGD: Conjugate vaccines for preventing Haemophilus influenza type B infections (Review). The Cochrane Library. 2009, 3: (Withdrawn)
  3. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2010, Accessed January 26, 2007 at http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt
  4. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012, 379 (9832): 2151-61. 10.1016/S0140-6736(12)60560-1. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11 · DOI · Paper page
  5. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL: Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010, 7 (10): pii: e1000348-10.1371/journal.pmed.1000348. · DOI · Paper page
  6. von Gottberg A, Madhi SA, Quan V, Soma K, Huebner R, Flannery B, Schuchat A, Klugman KP, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (Germ-SA): Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Pediatr Infect Dis J. 2004, 23 (9): 842-847. 10.1097/01.inf.0000137575.82874.0c. · DOI · Paper page
  7. Abate H, Falaschi A, Garcia B: Enfermedad invasiva por Haemophilus influenzae b: disminucion de la incidencia en la era postvaccinal. Arch Argent Pediatr. 2003, 101 (1): 26-30.
  8. Adegbola RA, Usen SO, Weber M, Lloyd-Evans N, Jobe K, Mulholland K, McAdam KPWJ, Greenwood BM, Milligan PJM: Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet. 1999, 354 (9184): 1091-1092. 10.1016/S0140-6736(99)03010-X. · DOI
  9. Agudelo CI, Muñoz N, De la Hoz F: Rapid assessment of the impact of Haemophilus influenzae vaccine serotype b in Colombia. Rev Panam Salud Publica. 2000, 8 (3): 181-184. 10.1590/S1020-49892000000800005. · DOI
  10. Almeida A, de Filippis I, de Abreu AO, Ferreira DG, Gemal AL, Marzochi KBF: Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine. Brazilian Journal of Medical and Biological Research. 2005, 38 (5): 777-781. · doi:10.1590/s0100-879x2005000500016
  11. Caro-Cassali M, Vargas-Campos A, Mohs-Villalta E, Arguedas-Mohs A: Invasive type B Haemophilus influenzae infections at the National Children's Hospital one year after the introduction of the conjugated vaccine. Bol Med Hosp Inf Mex. 1995, 52 (7): 426-430.
  12. Cisse MF, Breugelmans JG, BÄ M, Diop MB, Faye PC, Mhlanga B, Mueller JE, Koffi D, Gessner BD: The elimination of haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal. Pediatric Infectious Disease Journal. 2010, 29 (6): 499-503. · DOI
  13. Diaz JM, Catalan L, Urrutia MT, Prado V, Ledermann W, Mendoza C, Topelberg S: Trends of etiology of acute bacterial meningitis in Chilean children from 1989 to 1998: impact of the anti-H influenzae type b vaccine. Revista medica de Chile. 2001, 129 (7): 719-726.
  14. Dickinson FO, Perez AE, Galindo MA, Quintana I: [Impact of vaccination against Haemophilus influenzae type b in Cuba]. Rev Panam Salud Publica. 2001, 10 (3): 169-173. 10.1590/S1020-49892001000900004. · DOI
  15. Freitas HS, Merchan-Hamann E: [Impact of anti-Hib conjugate vaccine on the incidence of Haemophilus influenzae meningitis in Brazil's Federal District: Results of a three-year follow-up]. Revista Panamericana de Salud Publica. 2006, 19 (1): 33-37. 10.1590/S1020-49892006000100005. · doi:10.1590/s1020-49892006000100005
  16. Dickinson FO, Pérez AE: Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect Dis. 2005, 5: 103-10.1186/1471-2334-5-103. · DOI
  17. Lee HJE, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, Braka F, Flannery B, Zuber PL, Feikin DR: Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Tropical Medicine and International Health. 2008, 13 (4): 495-502. 10.1111/j.1365-3156.2008.02027.x. · DOI
  18. Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, Saloojee H, Crewe-Brown H, Klugman KP: Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. The Pediatric infectious disease journal. 2002, 21 (4): 315-321. 10.1097/00006454-200204000-00011. · DOI · Paper page
  19. Martin M, Casellas JM, Madhi SA, Urquhart TJ, Delport SD, Ferrero F, Chamany S, Dayan GH, Rose CE, Levine OS, et al: Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J. 2004, 23 (9): 842-847. 10.1097/01.inf.0000137575.82874.0c. · DOI · Paper page
  20. McCormick DW, Molyneaux E: Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi. Emerg Infect Dis. 2011, 17 (4): 688-690. 10.3201/eid1704.101045. · DOI
  21. Miranzi SS, de Moraes SA, de Freitas IC: Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil. Cadernos de saude publica Ministrio da Saude, Fundao Oswaldo Cruz, Escola Nacional de Saude Publica. 2007, 23 (7): 1689-1695. 10.1590/S0102-311X2007000700021. · doi:10.1590/s0102-311x2007000700021
  22. Montano Lotito AA, Algorta Rusinol MG, Pirez Garcia MC, Pascale Mello A, Farcilli Ruiz RI, Ferrari Chiesa AM: Enfermedades invasivas por Haemophilus influenzae tipo b. Impacto de la vacunacion en los ninos que ingresan al Centro Hospitalario Pereira Rossell. Rev Med Urug. 2001, 17 (3): 166-170.
  23. Muganga N, Uwimana J, Fidele N, Gahimbare L, Gessner BD, Mueller JE, Mhlanga BR, Katsande R, Herbinger K-H, Rugambwa C: Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda. Vaccine. 2007, 25: 7001-7005. 10.1016/j.vaccine.2007.06.032. · DOI
  24. Nascimento-Carvalho CM, Moreno-Carvalho OA: [Etiology of bacterial meningitis in a cohort from Salvador, Bahia]. Arq Neuropsiquiatr. 1998, 56 (1): 83-87. · DOI
  25. Nascimento-Carvalho CM, Moreno-Carvalho OA: Etiology of bacterial meningitis among children aged 2-59 months in Salvador, Northeast Brazil, before and after routine use of Haemophilus influenzae type B vaccine. Arq Neuropsiquiatr. 2004, 62 (2): 250-252. · DOI
  26. Pérez AE, Dickinson FO, Rodríguez M: Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infect Dis. 2010, 10: 130-10.1186/1471-2334-10-130. · DOI
  27. Renner LA, Newman MJ, Ahadzie L, Antwi-Agyei KO, Eshetu M: Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years. The Pediatric infectious disease journal. 2007, 26 (4): 356-358. 10.1097/01.inf.0000258693.19247.8e. · DOI
  28. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, Petersen M, Salgado K, Silva HR, Zanella RC, Almeida SC, et al: Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis. 2003, 187 (1): 109-116. 10.1086/345863. · DOI · Paper page
  29. Takemura NS, Andrade SM: Haemophilus influenzae type b meningitis in the state of Paraná, Brazil. J Pediatr (Rio J). 2001, 77 (5): 387-392.
  30. Verghese VP, Friberg IK, Cherian T, Raghupathy P, Balaji V, Lalitha MK, Thomas K, John TJ, Steinhoff MC: Community effect of haemophilus influenzae type b vaccination in India. Pediatric Infectious Disease Journal. 2009, 28 (8): 738-740. 10.1097/INF.0b013e318199f2a1. · DOI
  31. von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K, Huebner R, Flannery B, Schuchat A, Klugman K: Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ. 2006, 84 (10): 811-8. 10.2471/BLT.06.030361. · DOI · Paper page
  32. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, et al: Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997, 349 (9060): 1191-1197. 10.1016/S0140-6736(96)09267-7. · DOI · Paper page
  33. Fleming JA, Dieye Y, Ba O, Mutombo wa Mutombo B, Diallo N, Faye PC, Ba M, Cisse MF, Diallo AG, Slack MPE, et al: Effectiveness of Haemophilus influenzae type b conjugate vaccine for prevention of meningitis in Senegal. The Pediatric infectious disease journal. 2011, 30 (5): 430-2. 10.1097/INF.0b013e318203aaa0. · DOI
  34. Gessner BD, Sutanto A, Linehan M, Gede Djelantik IG, Fletcher T, Gerudug IK, Ingerani , Mercer D, Moniaga V, Moulton LH, et al: Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet (British edition). 2005, 365 (9453): 43-52. 10.1016/S0140-6736(04)17664-2. · DOI · Paper page
  35. Russell FM, Fakakovi T, Paasi S, Ika A, Mulholland EK: Reduction of meningitis and impact on under-5 pneumonia after introducing the Hib vaccine in the Kingdom of Tonga. Ann Trop Paediatr. 2009, 29 (2): 111-117. 10.1179/146532809X440725. · DOI
  36. Wilson N, Mansoor O, Wenger J, Martin R, Zanardi L, O'Leary M, Rabukawaqa V: Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji. Vaccine. 2003, 21 (17-18): 1907-1912. 10.1016/S0264-410X(02)00825-3. · DOI
  37. Lewis RE, K A, Gessner BD, et al: Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ. 2008, 86: 292-301. 10.2471/BLT.07.045336. · DOI · Paper page
  38. Baqui AH, ElArifeen S, Saha SK, Persson L, Zaman K, Gessner BD, Moulton LH, Black RE, Santosham M: Effectiveness of Haemophilus influenzae type b conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatric Infectious Disease Journal. 2007, 26 (7): 565-571. 10.1097/INF.0b013e31806166a0. · DOI · Paper page
  39. Dickinson Meneses FlO, Perez Rodriguez AE: Las meningoencefalitis bacterianas en la poblacion infantil cubana: 1998-2000. Revcubapediatr. 2002, 74 (2): 106-114.
  40. Simoes LL, Andrade AL, Laval CA, Oliveira RM, Silva SA, Martelli CM, Alves SL, Almeida RM, Andrade JG: [Impact of Haemophilus influenzae b (Hib) vaccination on meningitis in Central Brazil]. Revista de saude publica. 2004, 38 (5): 664-670. · DOI
  41. Lee EH, Corcino M, Moore A, Garib Z, Peña C, Sánchez J, Fernández J, Feris-Iglesias JsM, Flannery B: Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic Impacto de la vacuna conjugada contra Haemophilus influenzae tipo b sobre la meningitis bacteriana en la República Dominicana. Revista Panamericana De Salud Publica-Pan American Journal of Public Health. 2008, 24 (3): 161-168. 10.1590/S1020-49892008000900002. · DOI
  42. Kmetzsch CI, Schermann MT, Santana JC, Estima CL, Faraco FJ, Silva CM, Conceição R: Occurrence of Haemophylus influenzae B meningitis after the implementation of a mass vaccination program. J Pediatr (Rio J). 2003, 79 (6): 530-6.
  43. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM: Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. The Pediatric infectious disease journal. 1996, 15 (3): 216-222. 10.1097/00006454-199603000-00008. · DOI · Paper page
  44. Ribeiro GS, Lima JBT, Reis JN, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Ribeiro CT, Neves AB, Salgado K, et al: Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine. 2007, 25 (22): 4420-4428. 10.1016/j.vaccine.2007.03.024. · DOI
  45. Ruocco G, Curto S, Savio M, Laurani H, Frocht R: Vaccination against Haemophilus influenzae type b in Uruguay: experience and impact. Rev Panam Salud Publica. 1999, 5 (3): 197-199. 10.1590/S1020-49891999000300021. · doi:10.1590/s1020-49891999000300021
  46. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, Vaccine Trialists Group: A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003, 349 (14): 1341-1348. 10.1056/NEJMoa035060. · DOI · Paper page
  47. Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, et al: Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease inThe Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005, 365: 1139-46. 10.1016/S0140-6736(05)71876-6. · DOI · Paper page
  48. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012, 379 (9832): 2151-61. 10.1016/S0140-6736(12)60560-1. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11 · DOI · Paper page
  49. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012, 379 (9832): 2151-61. 10.1016/S0140-6736(12)60560-1. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11 · DOI · Paper page
  50. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL: Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010, 7 (10): pii: e1000348-10.1371/journal.pmed.1000348. · DOI · Paper page
  51. Griffiths UK, Clark A, Gessner B, Miners A, Sanderson C, Sedyaningsih ER, Mulholland KE: Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. Epidemiol Infect. 2012, 140: 1343-1355. 10.1017/S0950268812000957. · DOI
  52. Levine OS, Lagos R, Munoz A, Villaroel J, Alvarez AM, Abrego P, Levine MM: Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatric Infectious Disease Journal. 1999, 18: 1060-1064. 10.1097/00006454-199912000-00006. · DOI · Paper page
  53. Muganga N, Uwimana J, et al: Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda. Vaccine. 2007, 25: 7001-7005. 10.1016/j.vaccine.2007.06.032. · DOI
  54. Direct and Indirect Effects of Routine Vaccination of Children with 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease – Unites States, 1998-2003. MMWR. 2005, 54: 893-897.
  55. Stephens DS: Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics. Trans Am Clin Climatol Assoc. 2011, 122: 115-23.
  56. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN: Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010, 28 (24): 4073-8. 10.1016/j.vaccine.2010.03.075. doi: 10.1016/j.vaccine.2010.03.075. Epub 2010 Apr 14 · DOI · Paper page
  57. Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, et al: Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives : progress towards elimination of a health disparity. Vaccine. 2005, 23 (48-49): 5464-73. 10.1016/j.vaccine.2005.08.100. · DOI
  58. Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, Hadler J, et al: Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Int Med. 2006, 144 (1): 1-9. 10.7326/0003-4819-144-1-200601030-00004. · DOI · Paper page
  59. Whitney C: "Decline in Invasive Disease after the introduction of protein-polysaccharide conjugate vaccine.". NEJM. 2003, 348: 1737-46. 10.1056/NEJMoa022823. · DOI · Paper page
  60. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO and UNICEF: Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012, 379 (9832): 2151-61. 10.1016/S0140-6736(12)60560-1. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11 · DOI · Paper page
  61. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL: Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010, 7 (10): pii: e1000348-10.1371/journal.pmed.1000348. · DOI · Paper page
  62. Song JY, Nahm MH, Moseley MA: Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci. 2013, 28 (1): 4-15. 10.3346/jkms.2013.28.1.4. · DOI · Paper page

Cited by

See all 71

Metadata

Authors
Davis, S., Feikin, D., & Johnson, H. L.
Venue
BMC Public Health
Published
2013-09
Volume
13
Issue
S3
Pages
S21-S21
ISSN
1471-2458 (ISSN-L)
OpenAlex
W2071038330
Cited by
71
References
8
FWCI
1.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of Haemophilus influenzaetype B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review. https://app.cochat.ai/papers/10.1186/1471-2458-13-s3-s21
The paper
Davis, S., Feikin, D., & Johnson, H. L. (2013). The effect of Haemophilus influenzaetype B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review. BMC Public Health. https://doi.org/10.1186/1471-2458-13-s3-s21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.